A detailed history of Powers Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Powers Advisory Group, LLC holds 13,970 shares of PFE stock, worth $371,881. This represents 0.2% of its overall portfolio holdings.

Number of Shares
13,970
Previous 14,056 0.61%
Holding current value
$371,881
Previous $393,000 2.8%
% of portfolio
0.2%
Previous 0.21%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $2,382 - $2,699
-86 Reduced 0.61%
13,970 $404,000
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $14,145 - $16,576
560 Added 4.15%
14,056 $393,000
Q1 2024

Apr 19, 2024

BUY
$25.89 - $29.73 $14,265 - $16,381
551 Added 4.26%
13,496 $374,000
Q4 2023

Jan 17, 2024

SELL
$26.13 - $33.94 $21,269 - $27,627
-814 Reduced 5.92%
12,945 $372,000
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $10,557 - $12,340
329 Added 2.45%
13,759 $456,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $23,730 - $27,456
657 Added 5.14%
13,430 $492,000
Q1 2023

Apr 13, 2023

BUY
$39.39 - $51.28 $2,520 - $3,281
64 Added 0.5%
12,773 $521,000
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $2,922 - $3,815
70 Added 0.55%
12,709 $0
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $4,069 - $4,968
-93 Reduced 0.73%
12,639 $553,000
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $14,377 - $17,047
-309 Reduced 2.37%
12,732 $668,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $10,248 - $12,698
224 Added 1.75%
13,041 $675,000
Q4 2021

May 06, 2022

BUY
$41.32 - $61.25 $529,598 - $785,041
12,817 New
12,817 $757,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Powers Advisory Group, LLC Portfolio

Follow Powers Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Powers Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powers Advisory Group, LLC with notifications on news.